Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK Infinitopes Ltd has received UK regulatory approval to commence clinical trials for ITOP1, a novel vaccine targeting oesophageal cancer, showing promise in reducing recurrence rates.

Infinitopes Secures Approval for Groundbreaking Cancer Vaccine Clinical Trial in the UK #United_Kingdom #Oxford #Infinitopes #Oesophageal_Cancer #ITOP1